Antimicrobial Stewardship Backgrounders
- Issue 23, Nov 2022 – Bacitracin & Risks Associated With Use in Surgery
- Issue 22, Apr 2022 – Avoid Fluoroquinolones as First-line Therapy
- Issue 21, Jan 2022 – Enterococcal Bloodstream Infections
- Issue 20, Apr 2021 – Candidemia in Non-neutropenic Adults
- Issue 19, Feb 2021 – Amoxicillin-clavulanate IV
- Issue 18, Oct 2020 – Update on Vancomycin Dosing
- Issue 17, May 2019 – Ceftriaxone Dosing
- Issue 16, November 2018 – Fluoroquinolones
- Issue 15, June 2018 – Antibiotics for Gram positive Infections
- Issue 14, July 2017 – β-lactam Allergy
- Issue 13, April 2017 – Aspiration: Pneumonitis vs. Pneumonia
- Issue 12, January 2017 – Staphylococcus aureus Bacteremia in Adults
- Issue 11, April 2016 – Cefazolin + Probenecid for Outpatient Treatment of Uncomplicated SSTIs
- Issue 10, February 2016 – Use of Oseltamivir for the Treatment of Influenza
- Issue 9, January 2016 – Clindamycin in Dental Infections
- Issue 8, Oct 2015 – Optimizing Vancomycin Dosing & Monitoring
- Issue 7, May 2015 - C. difficile Infection
- Issue 6, March 2015 – The Day 3 Bundle: Tailoring Empiric Antimicrobial Therapy on Day 3
- Issue 5, October 2014 – Short Course Therapy for Community-acquired Pneumonia (CAP)
- Issue 4, August 2014 – Understanding Asymptomatic Bacteriuria
- Issue 3, June 2014 - IV to PO Antimicrobial Therapy Conversion
- Issue 2, April 2014 - revised Feb 2019 - Carbapenem Conundrum
- Issue 1, January 2014 - revised Feb 2019 - Meropenem Therapeutic Interchange
